Meiji Yasuda Asset Management’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-4,964
Closed -$398K 505
2016
Q4
$398K Buy
4,964
+1,280
+35% +$102K 0.04% 377
2016
Q3
$294K Buy
3,684
+990
+37% +$79.9K 0.03% 412
2016
Q2
$210K Sell
2,694
-1,215
-31% -$86.6K 0.03% 421
2016
Q1
$215K Sell
3,909
-660
-14% -$36K 0.05% 325
2015
Q4
$282K Buy
4,569
+960
+27% +$60.5K 0.06% 285
2015
Q3
$228K Buy
3,609
+110
+3% +$7.85K 0.06% 319
2015
Q2
$256K Buy
+3,499
New +$253K 0.06% 315
2015
Q1
Sell
-6,054
Closed -$394K 366
2014
Q4
$394K Buy
6,054
+2,070
+52% +$133K 0.09% 234
2014
Q3
$240K Sell
3,984
-380
-9% -$24.8K 0.06% 322
2014
Q2
$302K Buy
+4,364
New +$283K 0.06% 301
2013
Q4
Sell
-4,584
Closed -$246K 363
2013
Q3
$246K Sell
4,584
-2,430
-35% -$125K 0.06% 310
2013
Q2
$320K Buy
+7,014
New +$304K 0.08% 244

Other funds holding STJ

Meiji Yasuda Asset Management's STJ Position: Q1 2017 in Review

Meiji Yasuda Asset Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 4,964 shares — an estimated $398K sold.

Meiji Yasuda Asset Management first reported a position in STJ in Q2 2013 and held it in 12 quarters. The position peaked at $398K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Meiji Yasuda Asset Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Meiji Yasuda Asset Management sold 4,964 St Jude Medical shares in Q1 2017, an estimated $398K.
  • Meiji Yasuda Asset Management first reported a position in St Jude Medical in Q2 2013 and held it in 12 quarters.
  • Meiji Yasuda Asset Management's St Jude Medical position peaked at $398K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Meiji Yasuda Asset Management's 13F filing for Q1 2017, filed 12 May 2017.